<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To investigate the effects of <z:chebi fb="0" ids="36281">caffeic acid</z:chebi> <z:chebi fb="21" ids="35701">ester</z:chebi> fraction (Caf) from Erigeron breviscapus, mainly composed of dicaffeoylquinic acids (diCQAs), on microglial activation in vitro and focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in vivo </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The production of nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> (NO), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor α (TNF-α), and interleukin-1β (IL-1β) induced by <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi> (LPS) treatment in rat primary cultured microglia were measured by Griess reaction or enzyme-linked immunosorbent assay </plain></SENT>
<SENT sid="2" pm="."><plain>Cell viability of cortical neurons was measured using AlamarBlue reagent </plain></SENT>
<SENT sid="3" pm="."><plain>The behavioral tests and the <z:mpath ids='MPATH_124'>infarct</z:mpath> area of brain were used to evaluate the damage to central <z:mp ids='MP_0008912'>nervous</z:mp> system in rat middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Real time polymerase chain reaction was used to determine the expression of inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), TNF-α and IL-1β <z:chebi fb="2" ids="33699">mRNA</z:chebi> in ischemic cerebral tissues </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Caf inhibited the production of NO, TNF-α and IL-1β induced by LPS treatment in primary microglia in a dose-dependent manner </plain></SENT>
<SENT sid="6" pm="."><plain>Exposure of cortical neurons to conditioned medium from Caf-treated microglia increased neuronal cell viability (P&lt;0.01) compared with conditioned medium from LPS-treated alone </plain></SENT>
<SENT sid="7" pm="."><plain>In MCAO rat model of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, Caf could significantly improve neurobehavioural performance and reduce percentage <z:mpath ids='MPATH_124'>infarct</z:mpath> volume compared with the vehicle group (P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Caf could also significantly inhibit the up-regulation of iNOS, TNF-α, and IL-1β gene expressions in ischemic cerebral tissues </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Caf could suppress microglial activation, which may be one mechanism of its neuroprotective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>